Drugs.com

SEPTEMBER 20, 2024

20, 2024 -- The days of waiting for a flu shot at your doctor's office or local pharmacy may be over: The U.S. FRIDAY, Sept. Food and Drug Administration on Friday approved FluMist nasal spray as the first influenza vaccine that can be.

FDA Approval 279

FDA Approval Vaccine Pharmacy Doctors 279

Drugs.com

DECEMBER 19, 2024

19, 2024 -- The U.S. Department of Justice (DOJ) has filed a civil complaint against CVS Pharmacy Inc., accusing the nations largest pharmacy chain of unlawfully filling prescriptions for highly addictive opioids and violating f. THURSDAY, Dec.

Regulations 246

Regulations Pharmacy 246

Drugs.com

MARCH 6, 2024

WEDNESDAY, March 6, 2024 -- Barry Cadden, co-founder of a specialty compounding pharmacy behind a deadly meningitis outbreak in 2012, has been handed a prison sentence of 10 to 15 years in Michigan for involuntary manslaughter.On Tuesday, Cadden.

Compounding Pharmacies 298

Compounding Pharmacies Pharmacy 298

Drug Channels

NOVEMBER 15, 2023

In Medicare Part D in 2024: The Seven Largest Companies' Preferred Pharmacy Networks and the Coming Collapse of the PDP Market , I documented how those networks now dominate stand-alone Medicare Part D prescription drug plans (PDPs) and have become a major presence in Medicare Advantage prescription drug (MA-PD) plans. to 1:30 p.m.

Pharmacy 98

Pharmacy Drugs Marketing 98

Drugs.com

FEBRUARY 27, 2024

2, 2024 -- For nearly a week, prescription drug orders have been disrupted at thousands of pharmacies as the largest health insurer in the United States tries to fully restore services following a cyberattack. TUESDAY, Feb. The security breach was.

Pharmacy 264

Pharmacy Drugs 264

Drugs.com

OCTOBER 15, 2024

15, 2024 -- Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. TUESDAY, Oct. Food and Drug Administration revisits its Oct. 2 decision to remove the medicine from a national drug shortage.

Compounding Pharmacies 223

Compounding Pharmacies Pharmacy FDA Drugs 223

Drug Channels

MARCH 7, 2024

On March 19, 2024, Drug Channels Institute will release The 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. We are providing you with the opportunity to preorder this thoroughly updated, revised, and expanded 2024 edition at special discounted prices. prescription drug channels.

Pharmacy 98

Pharmacy Licensing Licensing Drugs 98

Drug Channels

MAY 7, 2024

It's time for Drug Channels ’ annual update of vertical integration among insurers, PBMs, specialty pharmacies, and providers within U.S. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. drug channels. All rights reserved. This Feed is for personal non-commercial use only.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Drugs 98

Drug Channels

JANUARY 23, 2024

In a previous article , I highlighted the largest pharmacy chains that will participate in the 2024 Medicare Part D prescription drug plans (PDP). As you will see below, the largest PSAOs have effectively abandoned PDP’s preferred networks in 2024. Look out below! All rights reserved.

Pharmacy 70

Pharmacy Independent Pharmacies Marketing Drugs 70

Drug Channels

APRIL 1, 2024

Despite skyrocketing sales for anti-obesity GLP-1 drugs, many retail pharmacies are losing money on every prescription. The common factor behind these two disparate situations: Pharmaceutical wholesalers’ unusual pricing for brand-name drugs sold to pharmacies, hospitals, and other buyers. All rights reserved.

Pharmacy 98

Pharmacy Hospitals Pharmaceuticals Drugs 98

Drug Channels

AUGUST 6, 2024

In the video excerpt below, I walk through a brief history of 340B contract pharmacies. I conclude with a “follow the dollar” example of 340B prescription economics with contract pharmacies. I conclude with a “follow the dollar” example of 340B prescription economics with contract pharmacies. All rights reserved.

Pharmacy 90

Pharmacy Hospitals Marketing Drugs 90

Drug Channels

APRIL 16, 2024

Drug Channels Institute’s (DCI’s) latest analysis finds that participants in the specialty pharmacy market continue to get more diverse—although revenues remain highly concentrated. Read on for DCI’s latest overview of the 2023 marketplace and revenues of the biggest market participants, along with key specialty pharmacy trends.

Specialty Pharmacies 96

Specialty Pharmacies Pharmacy Marketing Hospitals 96

Drug Channels

FEBRUARY 27, 2024

In this issue: An update on the retail pharmacy shakeout Arguing for high drug prices A leading researcher provides a 340B reality check Physicians don’t want pharmacists getting uppity Plus, Dave Grohl fights for your right to…have healthcare price transparency? Sorry, no Threads.) All rights reserved.

Pharmacy 95

Pharmacy Drugs Research International 95

Drug Channels

MARCH 12, 2024

Next week, Drug Channels Institute (DCI) will release our 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. We’re offering special discounted pricing if you order before April 7, 2024. How will the most consequential change in federal drug pricing policy affect the largest pharmacies and PBMs?

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

OCTOBER 9, 2024

Read on for five key pricing, pharmacy, provider, and manufacturer trends that are driving the U.S. For even more, check out DCI's new 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , the fifteenth edition of our deep dive into wholesale distribution channels. drug wholesaling industry.

Pharmacy 98

Pharmacy Drugs Pharmaceuticals Hospitals 98

Drug Channels

MARCH 25, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Find out during Drug Channel Implications of the Inflation Reduction Act , a new live video webinar with Adam J. Click here to learn more and reserve your spot at our April 5 webinar. All rights reserved.

Specialty Pharmacies 75

Specialty Pharmacies Pharmacy Hospitals Drugs 75

Drug Channels

DECEMBER 5, 2023

Despite skyrocketing sales for anti-obesity GLP-1 drugs, many retail pharmacies are losing money on every prescription. The common factor behind these two disparate situations: Pharmaceutical wholesalers’ unusual pricing for brand-name drugs sold to pharmacies, hospitals, and other buyers. to 1:30 p.m.

Pharmacy 98

Pharmacy Drugs Hospitals Pharmaceuticals 98

Drug Channels

APRIL 9, 2024

Three is still the magic number for pharmacy benefit managers (PBMs). Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved. This Feed is for personal non-commercial use only.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Patent Watch

DECEMBER 10, 2024

“India sometimes describes itself as the ‘pharmacy to the world’ because it is a significant global supplier of affordable therapeutics, including many life-saving medicines for chronic conditions.” India’s Unique Opportunity and Important Responsibility as “Pharmacy to the World.”

Government 97

Government Drugs Pharmacy Pharmaceuticals 97

Drug Channels

NOVEMBER 14, 2023

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live video webinar: Drug Channels Outlook 2024 This event will be broadcast live on Friday, December 15, 2023 12:00 p.m. Please note that our December 2023 webinar is *not* included with next year’s 2024 Video Webinar Series.)

Pharmacy 98

Pharmacy Drugs Biosimilars Marketing 98

Drug Channels

APRIL 2, 2024

For more on acquisition cost reimbursement for pharmacies, see Sections 8.4. of our new 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. Is the world ready for new ways to price pharmacy and pharmacy benefit manager (PBM) services? and 12.3.4. Et tu, Walgreens?)

Pharmacy 75

Pharmacy Drugs 75

Drug Channels

APRIL 29, 2024

on how Medicare Part D plans will react to the Inflation Reduction Act Walgreens' unexpected specialty pharmacy strength A video deconstruction of my infamous Drug Channels article on GoodRx Plus, a cartoonist illustrates my recent keynote on the battle for oncology margin.

Specialty Pharmacies 75

Specialty Pharmacies Pharmacy Biosimilars Drugs 75

Drug Channels

NOVEMBER 28, 2023

In this issue: A reality check on Express Scripts’ purported “cost-based” pharmacy network Mark Cuban explains how and why the PBM market will change Why two drug prices are better than one Pharmacists sing the retail pharmacy shakeout blues Plus, two Philly legends meet at a cardiology conference! I’m not posting to Threads yet.)

Pharmacy 97

Pharmacy Drugs Marketing 97

Drug Channels

OCTOBER 2, 2024

This week, I’m rerunning some popular posts while we put the finishing touches on DCI’s new 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Click here to see the original post from June 2024. The 340B contract pharmacy market shows little sign of slowing down. Fein, Ph.D.,

Pharmacy 52

Pharmacy Specialty Pharmacies Hospitals Marketing 52

Drug Channels

JUNE 12, 2024

The 340B contract pharmacy market shows little sign of slowing down. Drug Channels Institute’s exclusive analysis of the 2024 market reveals that: About 33,000 pharmacy locations—more than half of the entire U.S. For an updated look at what’s next for the 340B contract pharmacy market, join Adam J. Fein, Ph.D.,

Pharmacy 52

Pharmacy Specialty Pharmacies Hospitals Marketing 52

Drug Channels

JANUARY 9, 2024

For 2024, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and OptumRx (United Health Group)—have again each excluded 600 or more drugs from their standard formularies. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Biosimilars 98

Biosimilars Pharmacy Production Drugs 98

Drug Channels

DECEMBER 6, 2023

Is the world ready for new ways to price pharmacy and pharmacy benefit manager (PBM) services? I commend CVS Health for attempting to address key economic challenges facing the retail pharmacy industry and for tackling the hidden complexities of PBM pricing models. Below you'll find details and links to source documents.

Pharmacy 75

Pharmacy Drugs 75

Drug Channels

JANUARY 30, 2024

But who needs the Super Bowl when you can tackle this month’s selection of notable news stories, intercepted for you from the Drug Channels gridiron: Punt : Average list prices are unchanged for 2024 Trick Play : GSK tussles with PBMs over lower-priced products Rush! Check out the wonderful comments on this LinkedIn post. Great things ahead.

Hospitals 75

Hospitals Pharmacy Drugs Production 75

Drug Channels

JUNE 18, 2024

Click here to see the original post from April 2024. See The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents. In those exclusive networks, independent and smaller specialty pharmacies are the big winners. All rights reserved.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Drugs Production 52

Drug Channels

OCTOBER 21, 2024

Informa Connect’s Trade and Channel Strategies December 10-12, 2024 at the W Hotel in Philadelphia, PA Drug Channels readers save 10% with code 24DC10 * Pharmacy and distribution models are growing increasingly complex. Is my organization haemorrhaging money to stay afloat with the shift to alternative distribution and pharmacy models?

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Marketing Compliance 98

Drug Channels

APRIL 24, 2024

See The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents. In DCI’s exclusive analysis below, we show that specialty pharmacies affiliated with pharmacy benefit managers (PBMs) play an outsized role in manufacturer-designated dispensing networks.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Production Drugs 52

Common Sense for Drug Policy Blog

JUNE 7, 2024

Community Pharmacies and Harm Reduction "Community pharmacies are essential healthcare destinations that serve as an optimal resource for addressing non-urgent inquiries, such as safe injecting practices, management of adverse drug reactions, and medication provision, thus reducing the burden on general practitioners (GPs) [ 1 , 2 ].

Community Pharmacies 52

Community Pharmacies Pharmacy Treatment Drugs 52

FDA Law Blog: Biosimilars

MARCH 24, 2024

By Faraz Siddiqui — As drug manufacturers battle the Health Resources and Services Administration (“HRSA”) in federal courts over the role of 340B contract pharmacies, an Eighth Circuit decision to uphold a 2021 Arkansas law may render those cases inconsequential in that state. 22-3675, 2024 U.S. 2024) at 13 (“Decision”).

Pharmacy 59

Pharmacy Regulations Compliance Drugs 59

Drug Channels

OCTOBER 24, 2023

Open enrollment is under way for the 2024 Medicare Part D plans. Our exclusive analysis of Center for Medicare & Medicaid Services’ (CMS) data reveals that preferred cost sharing pharmacy networks will maintain their dominance as a component of Part D benefit design.

Pharmacy 52

Pharmacy Independent Pharmacies Marketing Drugs 52

Drug Channels

APRIL 4, 2024

For updated data on hospital-owned specialty pharmacies, see Chapter 3 of DCI's new 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. As many of you know, hospitals and health systems have emerged as significant participants in the specialty pharmacy industry.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Hospitals International 52

Fierce BioTech

DECEMBER 23, 2024

png Listing Introduction Join this webinar to receive expert guidance and learn key considerations for successfully planning pharmacy activities in early phase trials. Logos Attribution 0 Attribution 0 Primary Category Biotech On Demand Off Enable Automatic On Demand On Registration Login Link Already registered? Click here to login.

Pharmacy 52

Pharmacy Trials Clinical Trials Clinical Development 52

Common Sense for Drug Policy Blog

JUNE 7, 2024

Community Pharmacies and Anabolic-Androgenic Steroid Consumers "With the growing availability of AAS [Anabolic-Androgenic Steroids] through online platforms [ 71 , 72 ] the traditional reliance on social networks and healthcare providers for access to injecting equipment and safer use information has diminished [ 73 – 76 ]. Harm Reduct J.

Community Pharmacies 52

Community Pharmacies Pharmacy Research 52